Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Yoshihara

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Japanese Journal of Clinical Oncology|March 20, 2025
Long-term prognostic significance of ascites cytology in ovarian cancer cases in which R0 resection was achieved in the initial surgery: a multi-institutional retrospective cohort studyShohei Iyoshi, Mayuko Sunohara, Masato Yoshihara, et al.
Pharmacological Research|February 11, 2023
Novel therapeutic strategies targeting UCP2 in uterine leiomyosarcomaYukari Nagao, Akira Yokoi, Kosuke Yoshida, et al.
Biochemical and Biophysical Research Communications|October 2, 2023
Small Extracellular Vesicles from adipose-derived stem cells suppress cell proliferation by delivering the let-7 family of microRNAs in ovarian cancerHironori Suzuki, Akira Yokoi, Kaname Uno, et al.
Scientific Reports|July 2, 2025
Neutrophil infiltration in peritoneal metastasis affects prognosis in patients with ovarian cancerEmiri Miyamoto, Masato Yoshihara, Shohei Iyoshi, et al.
Cancer Metastasis Reviews|March 28, 2024
Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal disseminationHiroki Fujimoto, Masato Yoshihara, Raymond Rodgers, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 27, 2022
Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axisKazuhisa Kitami, Masato Yoshihara, Satoshi Tamauchi, et al.
Placenta|November 30, 2025
Natural-killer-cell-dominant immune landscape and HLA-E-mediated immune evasion in choriocarcinomaMayu Shibata, Kosuke Yoshida, Yuko Yasui, et al.
Journal of Extracellular Vesicles|May 15, 2026
DNA Copy Number Profiling in Extracellular Vesicles as Clinical Biomarkers of High-Grade Serous Ovarian CarcinomaRyosuke Uekusa, Akira Yokoi, Mayu Ukai, et al.
Cancer Immunology, Immunotherapy : CII|June 2, 2026
Integrated immunophenotypic and ProMisE molecular profiling as predictors of immune checkpoint inhibitor response in recurrent endometrial cancerKomei Katayama, Nobuhisa Yoshikawa, Wenting Liu, et al.
Medical Molecular Morphology|February 18, 2025
Vitamin D derivatives inhibit mesenchymal transition of mesothelial cells and mitigate peritoneal dissemination of ovarian cancerKazuhisa Fujita, Maia Hayashi, Masato Yoshihara, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Japanese Journal of Clinical Oncology|March 20, 2025
Long-term prognostic significance of ascites cytology in ovarian cancer cases in which R0 resection was achieved in the initial surgery: a multi-institutional retrospective cohort studyShohei Iyoshi, Mayuko Sunohara, Masato Yoshihara, et al.
Pharmacological Research|February 11, 2023
Novel therapeutic strategies targeting UCP2 in uterine leiomyosarcomaYukari Nagao, Akira Yokoi, Kosuke Yoshida, et al.
Biochemical and Biophysical Research Communications|October 2, 2023
Small Extracellular Vesicles from adipose-derived stem cells suppress cell proliferation by delivering the let-7 family of microRNAs in ovarian cancerHironori Suzuki, Akira Yokoi, Kaname Uno, et al.
Scientific Reports|July 2, 2025
Neutrophil infiltration in peritoneal metastasis affects prognosis in patients with ovarian cancerEmiri Miyamoto, Masato Yoshihara, Shohei Iyoshi, et al.
Cancer Metastasis Reviews|March 28, 2024
Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal disseminationHiroki Fujimoto, Masato Yoshihara, Raymond Rodgers, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 27, 2022
Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axisKazuhisa Kitami, Masato Yoshihara, Satoshi Tamauchi, et al.
Placenta|November 30, 2025
Natural-killer-cell-dominant immune landscape and HLA-E-mediated immune evasion in choriocarcinomaMayu Shibata, Kosuke Yoshida, Yuko Yasui, et al.
Journal of Extracellular Vesicles|May 15, 2026
DNA Copy Number Profiling in Extracellular Vesicles as Clinical Biomarkers of High-Grade Serous Ovarian CarcinomaRyosuke Uekusa, Akira Yokoi, Mayu Ukai, et al.
Cancer Immunology, Immunotherapy : CII|June 2, 2026
Integrated immunophenotypic and ProMisE molecular profiling as predictors of immune checkpoint inhibitor response in recurrent endometrial cancerKomei Katayama, Nobuhisa Yoshikawa, Wenting Liu, et al.
Medical Molecular Morphology|February 18, 2025
Vitamin D derivatives inhibit mesenchymal transition of mesothelial cells and mitigate peritoneal dissemination of ovarian cancerKazuhisa Fujita, Maia Hayashi, Masato Yoshihara, et al.
Pageof 13